Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation
The erythrocyte sedimentation rate in HIV: a neglected parameter?
Broadening of CD8+ cell responses in vaccine-based simian immunodeficiency virus controllers
Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals
Impact of atazanavir-based HAART regimen on the carotid intima–media thickness of HIV-infected persons: a comparative prospective cohort
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
HIV, HAART, and lipoprotein particle concentrations in the Women's Interagency HIV Study
Extended antenatal antiretroviral use correlates with improved infant outcomes throughout the first year of life
High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study
A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people
Assessing the impact of mass rape on the incidence of HIV in conflict-affected countries
Insights into the rise in HIV infections, 2001 to 2008: a Bayesian synthesis of prevalence evidence
Women's morbidity and mortality in the first 2 years after delivery according to HIV status
Pandemic influenza A (H1N1) in HIV-1-infected patients
Central nervous system disorders after starting antiretroviral therapy in South Africa
HIV vaccines: sin boldly!
Is Kaposi's sarcoma occurring at higher CD4 cell counts over the course of the HIV epidemic?
Erythropoiesis in HIV-infected and uninfected Malawian children with severe anemia
Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients
Evidence is still required for treatment as prevention for riskier routes of HIV transmission
Reply to ‘Evidence is still required for treatment as prevention for riskier routes of HIV transmission’